Unlock instant, AI-driven research and patent intelligence for your innovation.

glu-asp-gly modified methotrexate, its synthesis, antimetastatic activity and application

A glu-asp-gly, methotrexate technology, applied in the field of biomedicine, can solve the problems of limiting the application and curative effect of methotrexate

Active Publication Date: 2022-08-02
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, bone marrow toxicity, liver toxicity, nephrotoxicity, oral mucosal side effects and drug resistance severely limit the application and efficacy of methotrexate.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • glu-asp-gly modified methotrexate, its synthesis, antimetastatic activity and application
  • glu-asp-gly modified methotrexate, its synthesis, antimetastatic activity and application
  • glu-asp-gly modified methotrexate, its synthesis, antimetastatic activity and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Example 1 Preparation of Boc-Asp(OBzl)-Gly-OBzl(1)

[0017] 1.42 g (4.40 mmol) of Boc-Asp (OBzl) was dissolved in 60 mL of anhydrous tetrahydrofuran to obtain No. 1 solution. Under stirring, 1.36 g (6.60 mmol) of dicyclohexylcarbodiimide and 0.59 g (4.40 mmol) of N-hydroxybenzotriazole in anhydrous tetrahydrofuran were added to No. 1 solution and stirred for 30 minutes at 0°C. Subsequently, 1.10 g (3.26 mmol) of Tos·Gly-OBzl was added, the pH of the reaction solution was adjusted to 8-9 with N-methylmorpholine, the ice bath was removed, and after stirring at room temperature for 18 hours, TLC (dichloromethane / Methanol = 30 / 1) showed that the reaction was complete. The colorless solid in the reaction solution was filtered off, the filtrate was concentrated, the residue was dissolved in 100 mL of ethyl acetate, and the solution was washed with saturated aqueous sodium bicarbonate solution (30 mL × 3) and saturated aqueous sodium chloride solution (30 mL × 3) in turn. ,...

Embodiment 2

[0018] Example 2 Preparation of Asp(OBzl)-Gly-OBzl(2)

[0019] Dissolve 1.34g (2.85mmol) of Boc-Asp(OBzl)-Gly-OBzl(1) with anhydrous ethyl acetate, add 20mL of hydrogen chloride in ethyl acetate solution (4M) under stirring at 0°C, and stir for 7 hours. TLC (dichloromethane / methanol=30 / 1) showed that the reaction was completed. Under the condition of a warm water bath, the reaction solution was repeatedly concentrated under reduced pressure, and then the concentrate was dissolved in anhydrous ethyl acetate, and the reaction solution was repeatedly concentrated under reduced pressure (3 times), The reactant was repeatedly triturated with anhydrous ether to obtain 1.05 g (100%) of the target compound as a yellow viscous oil. ESI-MS(m / e): 371[M+1] + .

Embodiment 3

[0020] Example 3 Preparation of Boc-Glu(OBzl)-Asp(OBzl)-Gly-OBzl(3)

[0021] Using the method of Example 1, 1.31 g (77%) of the title compound was obtained as a colorless powder from 0.83 g (2.47 mmol) of Boc-Glu (OBzl) and 1.05 g (2.84 mmol) of compound (2). ESI-MS(m / e): 690[M+H] + , 1H NMR (300MHz, DMSO-d 6 ): δ / ppm=8.32(t, J=5.7Hz, 1H), 8.24(d, J=8.1Hz, 1H), 7.39-7.30(m, 15H), 7.03(d, J=7.8Hz, 1H) ,5.10-5.06(m,6H),4.71(m,1H),3.90(m,3H),2.81(dd,J=8.4Hz,5.1Hz,2H),2.52(m,2H),1.83(m, 2H), 1.36 (s, 9H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses Glu-Asp-Gly modified methotrexate of the following general formula (wherein R 1 R when Glu‑Asp‑Gly 2 for OH,R 1 R when OH 2 for Glu‑Asp‑Gly, and R 1 and R 2 At the same time, it is Glu-Asp-Gly), their preparation method is disclosed, and their inhibitory effect on tumor metastasis is disclosed. Therefore, the present invention discloses their application in the preparation of anti-tumor metastases.

Description

technical field [0001] The present invention relates to Glu-Asp-Gly modified methotrexate, to their preparation method and to their anti-tumor metastasis effect. Therefore, the present invention relates to their application in the preparation of anti-tumor metastases. The invention belongs to the field of biomedicine. Background technique [0002] Cancer refers to the uncontrolled and abnormal proliferation of cells, and has the opportunity to spread and metastasize to other parts through the blood system or lymphatic system of the body. It is a major medical problem in the world. According to the data on the incidence and death of malignant tumors in various regions in my country in 2015 released by the National Cancer Center in early 2019, leukemia ranks among the top ten malignant tumors with the highest mortality rate. As one of the earliest drugs used in the treatment of acute leukemia, methotrexate has a clinical history of more than 70 years. However, bone marrow t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K5/113C07K5/037C07K7/02C07K1/06C07K1/02A61K38/07A61K38/08A61P35/04
CPCC07K5/1021C07K5/0215C07K7/02A61P35/04A61K38/00Y02P20/55
Inventor 赵明彭师奇梁梦
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES